MCMC
VCYT icon

Matrix Capital Management Company’s Veracyte VCYT Stock Holding History

Matrix Capital Management Company’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,977,027
Closed -$160M – 28
2021
Q1 		$160M Buy
+2,977,027
New +$171M 1.85% 20

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Matrix Capital Management Company's VCYT Position: Q2 2021 in Review

Matrix Capital Management Company sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 2,977,027 shares — an estimated $160M sold.

Matrix Capital Management Company first reported a position in VCYT in Q1 2021 and held it in 1 quarter. The position peaked at $160M in Q1 2021. 215 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Matrix Capital Management Company reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Matrix Capital Management Company sold 2,977,027 Veracyte shares in Q2 2021, an estimated $160M.
  • Matrix Capital Management Company first reported a position in Veracyte in Q1 2021 and held it in 1 quarter.
  • Matrix Capital Management Company's Veracyte position peaked at $160M in Q1 2021.
  • 215 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Matrix Capital Management Company's 13F filing for Q2 2021, filed 16 Aug 2021.